Current GLP-1 Status: As of June 30, 2025, Boothwyn agreed with the FDA to temporarily cease all sterile injectable GLP-1 production and to notify the FDA before resuming
Dose progression strategy The standard tirzepatide titration schedule begins at 2.5 mg per week for the first four weeks, then increases by 2.5 mg increments every four weeks as tolerated, up to a maximum of 15 mg per week
It is typically sold for research purposes only
Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP and GLP-1 receptor agonist that affects how your body regulates blood sugar and processes food
Other studies in which both GSH and GSSG were assessed further revealed significant increases in GSSG between asthmatics and controls, particularly in the bronchial versus the alveolar airspaces (166, 234), with no differences in GSH concentrations between groups (52, 166)